Strong patient demand and expanding trial sites are helping Paradigm progress its long-awaited phase III knee OA study.
Some doctors are prescribing weight-loss drugs such as Zepbound and Ozempic to help reduce cravings for illicit drugs and ...
A federal bankruptcy court judge on Friday said he will approve OxyContin-maker Purdue Pharma’s latest deal to settle ...